These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25292180)

  • 1. Interleukin-driven insulin-like growth factor promotes prostatic inflammatory hyperplasia.
    Hahn AM; Myers JD; McFarland EK; Lee S; Jerde TJ
    J Pharmacol Exp Ther; 2014 Dec; 351(3):605-15. PubMed ID: 25292180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 induces IGF-dependent epithelial proliferation in prostate development and reactive hyperplasia.
    Jerde TJ; Bushman W
    Sci Signal; 2009 Sep; 2(86):ra49. PubMed ID: 19724062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis.
    Popovics P; Cai R; Sha W; Rick FG; Schally AV
    Prostate; 2018 Sep; 78(13):970-980. PubMed ID: 29786867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia.
    Wang Z; Olumi AF
    Differentiation; 2011; 82(4-5):261-71. PubMed ID: 21536370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostate.
    McIlwain DW; Zoetemelk M; Myers JD; Edwards MT; Snider BM; Jerde TJ
    Prostate; 2016 Jun; 76(8):722-34. PubMed ID: 27088546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukins, IGF and stem cells in BPH.
    McLaren ID; Jerde TJ; Bushman W
    Differentiation; 2011; 82(4-5):237-43. PubMed ID: 21864972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of prostate epithelial progenitor cells after inflammation of the mouse prostate.
    Wang L; Zoetemelk M; Chitteti BR; Ratliff TL; Myers JD; Srour EF; Broxmeyer H; Jerde TJ
    Am J Physiol Renal Physiol; 2015 Jun; 308(12):F1421-30. PubMed ID: 25925259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin-like growth factor system in the prostate.
    Peehl DM; Cohen P; Rosenfeld RG
    World J Urol; 1995; 13(5):306-11. PubMed ID: 8581002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 10 (TLR10) exhibits suppressive effects on inflammation of prostate epithelial cells.
    Fan Y; Yang L; Wei Q; Ding Y; Tang Z; Tan P; Lin T; Guo D; Qiu S
    Asian J Androl; 2019; 21(4):393-399. PubMed ID: 30618413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
    Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
    J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia.
    Xu C; Xu Y; Shen Z; Zhou H; Xiao J; Huang T
    Int Urol Nephrol; 2018 Apr; 50(4):611-617. PubMed ID: 29460133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels.
    Bonnet P; Reiter E; Bruyninx M; Sente B; Dombrowicz D; de Leval J; Closset J; Hennen G
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1203-8. PubMed ID: 7521342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
    Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
    Lai KP; Huang CK; Fang LY; Izumi K; Lo CW; Wood R; Kindblom J; Yeh S; Chang C
    Mol Endocrinol; 2013 Oct; 27(10):1617-31. PubMed ID: 23893956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens.
    Monti S; Di Silverio F; Lanzara S; Varasano P; Martini C; Tosti-Croce C; Sciarra F
    Steroids; 1998; 63(5-6):362-6. PubMed ID: 9618803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin growth factor I (IGF-I) in normal, hyperplastic, and tumor prostatic tissue].
    Téllez Martínez-Fornés M; Balsa J; Maganto Pavón E; Jiménez Cidre M; Burgos Revilla FJ
    Actas Urol Esp; 1996 May; 20(5):409-13. PubMed ID: 8766797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-ARI induces autophagy of prostate epithelial cells through suppressing IGF-1 expression in prostate fibroblasts.
    Yang BY; Jiang CY; Dai CY; Zhao RZ; Wang XJ; Zhu YP; Qian YX; Yin FL; Fu XY; Jing YF; Han BM; Xia SJ; Ruan Y
    Cell Prolif; 2019 May; 52(3):e12590. PubMed ID: 30883989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.